Sort   by:  
 Page size 
UnknownAtri-U: assisted image analysis in routine cardiovascular magnetic resonance volumetry of the left atrium.
Not available
S-EPMC8582149 | biostudies-literature
UnknownATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer's disease and Alzheimer's disease-related dementias clinical trails.
Not available
S-EPMC8826990 | biostudies-literature
UnknownUltrasoundelastography: Can it provide valid information for differentiation of benign and malignant thyroid nodules?
Not available
S-EPMC3558058 | biostudies-literature
UnknownEvaluation of [18F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer.
Not available
S-EPMC5524211 | biostudies-literature
GenomicsscRNA-seq of mouse immune compartment from tumours treated with ATRi ceralasertib (AZD6738)
scRNA-seq of mouse immune compartment from tumours treated with ATRi ceralasertib (AZD6738)
PRJEB71928 | ENA
TranscriptomicsTargeting ATR offers multifaceted treatment strategies involving RAD51-mediated compensatory DNA repair in bladder cancer
Background: Muscle-invasive bladder cancer treatment depends on histological and molecular subtypes. While urothelial carcinoma (UC) benefits from diverse therapies, options beyond radical cystectomy for rare subtypes such as squamous cell carcinoma (SCC) remain limited. We previously demonstrated t...
ORGANISM(S): Homo sapiens 
2026-01-28 | GSE301614 | GEO
UnknownTest-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.
Not available
S-EPMC3291175 | biostudies-literature
GenomicsCRISPR data for "HDAC3 inhibition enhances ATR inhibitor efficacy in CDK8-deficient cells by inducing transcriptional stress"
Brunello genome-wide CRISPR screen data in WT and CDK8-knockout HAP1-Cas9 treated with ATRi (AZD6738) or DMSO
PRJEB96732 | ENA
ProteomicsResistance to ATR Inhibitors Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2
Over one million cases of gastric cancer are diagnosed each year and metastatic disease continues to have a poor prognosis. A significant proportion of gastric tumors have defects in the DNA damage response pathway creating therapeutic opportunities through synthetic lethal approaches. In particular...
ORGANISM(S): Homo sapiens (Human) 
2022-11-06 | PXD034887 | Pride
Upf2 Gastric cancer Ab Ph Nmd 
TranscriptomicsKEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant NSCLC
KRAS mutations frequently co-occur with alterations in STK11/LKB1 and/or KEAP1, defining an aggressive subset of tumors associated with resistance to immuno- and chemotherapy. While LKB1 loss is associated with vulnerability to DNA-damage response (DDR)-based therapies, the impact of KEAP1 alteratio...
ORGANISM(S): Mus musculus 
2025-06-15 | E-MTAB-15235 | biostudies-arrayexpress
Sort   by:  
 Page size